Stay updated with breaking news from Tumor Microenvironment Activable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MediLink Therapeutics ("MediLink"), announced today that it has entered into a worldwide collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: ...
BioNTech gains rights to a MediLink Therapeutics antibody drug conjugate that targets tumors expressing the HER3 protein. The deal comes six months after the German company entered the ADC field by acquiring rights to two therapeutic candidates from DualityBio.
SAN ANTONIO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 9, 2023--
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The chair of this meeting was Professor Li Zhang, from the Cancer Center ...
/PRNewswire/ -- On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to...